TrialDiabetes, obesity & metabolism2017

Evaluation of the counter-regulatory responses to hypoglycaemia in patients with type 1 diabetes during opiate receptor blockade with naltrexone.

Sarita Naik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.